Dermatitis occurring during therapy with tripelennamine hydrochloride (pyribenzamine hydrochloride).
EPSTEIN
E
E
D003872:Dermatitis; D003875:Drug Eruptions; D006801:Humans; D014309:Tripelennamine / Q000633:toxicity*
D014309:Tripelennamine
DRUGS/eruptions; PYRIBENZAMINE/toxicity